Research News
- Anti-epileptic drug VPA can be used to treat Multiple Sclerosis
- SIMM explores the activation mechanism of ErbB4
- SIMM develops a theoretical model for calculating voltage sensitivity of ion channels
- The first-in-class anti-HBV drug, isothiafludine, approved for clinical trial
- The first-in-class anti-HBV drug, isothiafludine, approved for clinical trial
- SIMM Receives funding from NIH
- Article published in Asian Journal of Andrlogy draws worldwide attention
- Identification of Lysine Malonylation as a Novel Protein Modificationand Its Regulatory Enzyme
- Two Platforms for Early Stage Drug Safety Evaluation Targeting hERG Channel Launched
- SIMM identifies a novel antibacterial agent against multiple resistant bacteria
- The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma
- SIMM discovers a new class of potent antimitotic agents
- T33-A novel PPARα/γ dual agonist with potential effect on ischemia stroke treatment
- SIMM discovers unique isonitrile lipid and phidianidines from opisthobranch molluscs
- SIMM isolates unique compounds from mangrove plants